Prof. Sean P. J. Whelan
Vesicular stomatitis virus vectored vaccine for SARS-CoV-2
Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, USA
Speakers
Prof. Dor Ben-Amotz
Optimally Pooled COVID-19 Testing
Purdue University, Department of Chemistry West Lafayette, IN, USA
Prof. Rafael Franco
The renin angiotensin system (RAS) involvement in SARS-CoV-2 infection. ACE2 interacts with other RAS components to form complexes that are expressed in the lung.
Universidad de Barcelona. Barcelona, Spain
Dr Delia Goletti
Baricitinib as a potential drug for COVID-19: evidence from a multicenter trial and translational research studies
National Institute for Infectious Disease L. Spallanzani, Rome, Italy
Prof. Y-h. Taguchi
In silico drug discovery for COVID-19 using gene expression profiles of mouse infected by MHV and those of human cell lines infected by SARS-CoV-2
Department of Physics, Chuo University, Tokyo, Japan
Prof. Dr Barry Robson
Internet Knowledge Mining tools and A.I. For Rapid Response to New Pandemics with Proposals for Synthetic Vaccines and Therapeutics. The Example of COVID19
Ingine Inc. Cleveland Ohio, USA
Prof. Manuela Teresa Raimondi
Bioengineering tools to speed up the discovery and preclinical testing of vaccines for SARS-CoV-2 and therapeutic agents for COVID-19
Politecnico di Milano, Milano, Italy
Prof. Antonio Bianconi
Contolling the second Covid-19 wave by Mandatory Mobile Contact Tracing (MMCT) Containment and Time Dependent Doubling Time Control
Rome International Center for Materials Science, Superstripes, Roma, Italy
Prof. Craig B. Wilen
Genome-wide CRISPR screen reveals host genes that regulate SARS-CoV-2 infection
Yale School of Medicine Departments of Laboratory Medicine & Immunobiology, New Haven, USA
Prof. Rushika Perera
Innovative Therapeutic Interventions for SARS-CoV-2 – exploiting metabolic synergy
Arthropod-borne & Infectious Diseases Laboratory Colorado State University, USA
Prof. Maurizio Salvadori
SARS-CoV-2 Associated Nephropathy in the Pandemic Era
Department of Nephrology and Transplantation, University of Florence, Florence, Italy
Prof. Licia Iacoviello
COVID 19 Risk factors and therapies in Italy: results from the CORIST collaboration
IRCCS Neuromed, Pozzilli & University of Insubria Varese, Italy
Dr Tibor Bakács
The Clinically Validated Viral Superinfection Therapy (SIT) Platform Technology May Mitigate Severe Cases of COVID-19 Infections
Hungarian Academy of Sciences & HepC Inc, Hungary
Dr Jeremy W Prokop
SARS-CoV-2 mechanisms of severe outcomes
Department of Pharmacology & Toxicology, Michigan State University, Grand Rapids, USA
Prof. Susan R. Weiss
Coronaviruses: History and Biology
Penn Center for Research on Coronaviruses & Emerging Pathogens, University of Pennsylvania, USA
Prof. Jianyu Rao
Potential connections of COVID-19 and prostate cancer – the TMPRSS2 story
UCLA Medical Center, Santa Monica, LA, USA
Dr Bruna Corradetti
Stem cells from gestational tissues: a promising tool to restore the body’s own potential to fight SARS-CoV-2 infections
Houston Methodist Research Institute, USA
Prof. Panagiotis Skendros
Complement and neutrophil-mediated immunothrombosis: lessons from COVID-19
Democritus University of Thrace (DUTH), University Hospital of Alexandroupolis, Greece
Prof. Adela Cota-Gomez
Targeting the Master Regulator of Cellular Redox Homeostasis, Nrf2, in SARS-CoV-2 Infection
Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, USA
Prof. Ravi Mahalingam
Lessons learned from animal models of COVID-19
University of Colorado Anschutz Medical Campus, USA
Prof. Mircea T. Sofonea
Epidemiological monitoring and comparative analysis of non-pharmaceutical interventions using a non-Markovian modelling framework
University of Montpellier, France
Prof. Eleftherios Mylonakis
Spatiotemporal analysis of micro-epidemics of influenza and COVID-19
Alpert Medical School of Brown University, Rhode Island Hospital & The Miriam Hospital, USA
Prof. James Cai
Machine learning analysis of single-cell gene regulatory networks reveals potential mechanisms of action of antimalarials against SARS-CoV-2
Texas A&M University, USA
Dr Laura Lamb
Developing a Point-of-Risk Molecular Test for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Oakland University William Beaumont School of Medicine, Rochester Hills, Michigan, USA
Dr Corrado Pelaia
Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications
University “Magna Græcia” of Catanzaro, Italy
Dr Hanalise V Huff
Asymptomatic transmission during the COVID-19 pandemic and implications for public health strategies
Boston Children’s Hospital, Harvard Medical School, USA
Prof. Mikhail Sheianov
Pulse Therapy with Corticosteroids and Intravenous Immunoglobulin in the Management of Severe COVID-19. Unusual Treatment with Intriguing Results
Burnasyan Federal Medical Biophysical Center,Moscow, Russia
Prof. Antonio Facchiano
Molecular basis of COVID-19 comorbidities
Istituto Dermopatico dell’Immacolata (IDI-IRCCS), Rome, Italy
Prof. Luis Beltrán Ramos-Sánchez
EARLY PREDICTION OF COVID-19 IN CUBA USING THE SEIR MODEL
University of Camagüey, Camagüey, Cuba
Prof. Padma Srikanth
Covid-19, The King of 2020: lessons learned and still learning from a tertiary care centre in Chennai, India
Dept of Microbiology, Sri Ramachandra Institute, India
Dr Michael Baclig
Laboratory Biosafety in the Time of COVID-19
St. Luke’s Medical Center, Philippines
Christian Arias Reyes
The higher the altitude the less COVID-19: Decreased incidence, transmission capacity of the virus and severity at altitude in the American continent
Faculty of Medicine, Université Laval, Québec, QC, Canada
Dr Johan Lundberg
COVID-19 pathophysiology may be driven by a loss of inhibition of the Renin-Angiotensin-Aldosterone System
Karolinska University Hospital, Stockholm, Sweden
Dr. Manos Vlasiou
Screening Possible Drug Molecules for Covid-19: A Computational Study based on Docking Studies & Molecular Dynamics to Design New Inhibitor Candidates
Department of Health and Life Sciences, University of Nicosia, Nicosia, Cyprus
Prof. A. Ozlem Tastan Bishop
Allosteric site of SARS-CoV-2 main protease as drug target in the presence of its emerging mutations
Department of Biochemistry and Microbiology, Rhodes University, South Africa
Dr Syed Sikander Azam
Vaccine and Drug Designing for COVID-19- Research and Prevention Strategies
Quaid-i-Azam University, Islamabad, Pakistan
Dr. Muhamed Amin
How Molecular Modelling Could help in the COVID19 Crisis
University of Groningen, Groningen, Netherlands
Dr Dicky L. Tahapary
Weighing The Impact of Obesity on COVID-19 in Low- to Middle-Income Countries
Faculty of Medicine Universitas Indonesia (RSCM-FKUI), Indonesia
Dr Mushtaq Hussain
Allelic Variations in ACE2 and Natural Resistance against COVID-19
Dow University of Health Sciences, Karachi, Pakistan
Dr Efstratios Stratikos
Generation of SARS-CoV-2 S1 spike glycoprotein putative antigenic epitopes in vitro by intracellular aminopeptidases
National Center for Scientific Research Demokritos, Greece
★ Agenda is being updated regularly
2020@European Society for Translational Medicine (EUSTM)
